IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 161 a 180 di 512
Titolo Data di pubblicazione Autore(i) File
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. 1-gen-2000 Gruner, Nh; Gerlach, Tj; Jung, M. C.; Diepolder, Hm; Schirren, Ca; Schraut, Ww; Hoffmann, R; Zachoval, R; Santantonio, TERESA ANTONIA; Cucchiarini, M; Cerny, A; Pape, G. R.
Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. 1-gen-2000 Santantonio, TERESA ANTONIA; Mazzola, M; Iacovazzi, T; Miglietta, A; Guastadisegni, A; Pastore, G.
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection 1-gen-2000 Cacciola, I; Pollicino, T; Squadrito, G; Cerenzia, G; Villari, D; DE FRANCHIS, R; Santantonio, TERESA ANTONIA; Brancatelli, S; Colucci, G; Raimondo, G.
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. 1-gen-2000 Cucchiarini, M; Kammer, Ar; Grabscheid, B; Diepolder, Hm; Gerlach, Tj; Gruner, N; Santantonio, TERESA ANTONIA; Reichen, J; Pape, Gr; Cerny, A.
Virologic and clinical expression of reciprocal inhibitory effect of Hepatitis B, C, and Delta viruses in patients with chronic hepatitis 1-gen-2000 Sagnelli, E; Coppola, N; Scolastico, C; Filippini, P; Santantonio, TERESA ANTONIA; Stroffolini, T; Piccinino, F.
Long term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis 1-gen-2000 Santantonio, TERESA ANTONIA; Mazzola, M.; Sinisi, E.; Insalata, M.; Milella, M.; Guastadisegni, A.; Pastore, G.
Hepatitis B virus (HBV) reinfection in liver transplant patients receiving hepatitis B immune globulins: role of S mutants 1-gen-2000 Santantonio, TERESA ANTONIA; Marzano, A.; Mazzola, M.; Guastadisengni, A.; Rendina, M.; Mangia, A.; Bellati, G.; Gaeta, G. b.; Francavilla, A.; Pastore, G.
Correlation of the CD8+ and CD4+ T cell response during spontaneous clearance of hepatitis C virus 1-gen-2000 Gruener, N. h.; Jung, M. c.; Diepolder, H. m.; Gerlach, J. t.; Zachoval, R.; Hoffman, R.; Schraut, W.; Schirren, C. a.; Santantonio, TERESA ANTONIA; Pape, G. r.
The HBV immune escape mutant Gly145Arg shows a defect for secretion of virions 1-gen-2000 Sterneck, M.; Kalinina, T.; Santantonio, TERESA ANTONIA; Riu, A.; Fischer, L.; Will, H.
Detection of HCV-specific CD8+ T cells in acute hepatitis C which are impaired in cytolytic function and production of cytokines 1-gen-2000 Gruener, N. h.; Lechner, F.; Jung, M. c.; Diepolder, H.; Gerlach, T. j.; Zachoval, R. z.; Schraut, W.; Schirren, A. c.; Santantonio, TERESA ANTONIA; Klenerman, P.; Pape, G. r.
Recurrent hepatitis B virus (HBV) infection in immune globulin-treated liver transplant patients: role of S mutants 1-gen-2000 Santantonio, TERESA ANTONIA; Marzano, A.; Sinisi, E.; Mazzola, M.; Guastadisengni, A.; Rendina, M.; Mangia, A.; Bellati, G.; Gaeta, G. b.; Francavilla, A.; Pastore, G.
Treatment of acute hepatitis C with interferon alfa-2b. 1-gen-2001 Jaeckel, E; Cornberg, M; Wedemeyer, H; Santantonio, TERESA ANTONIA; Mayer, J; Zankel, M; Pastore, G; Dietrich, M; Trautwein, C; Manns, M. P.
Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis 1-gen-2001 Santantonio, TERESA ANTONIA; Sinisi, E.; Mazzola, M.; Insalata, M.; Guastadisegni, A.; Pastore, G.
Twelve months of lamivudine/Interferon combination therapy prevents the appearance of YMDD mutants in patients with anti-HBe positive chronic hepatitis B: a controlled pilot study 1-gen-2001 Santantonio, TERESA ANTONIA; Niro, G.; Insalata, M.; Sinisi, E.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G.
Clinical and histological outcome of extended lamivudine in patients with HBeAg negative chronic hepatitis B 1-gen-2001 Esteban, R. d. g.; Tassopoulos, N. c.; Rizzetto, M.; Santantonio, TERESA ANTONIA; Heathcote, J.; Woessner, M.; Taak, N. k.
Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-HBe positive chronic hepatitis B patients: a controlled pilot study 1-gen-2001 Santantonio, TERESA ANTONIA; Niro, G.; Sinisi, E.; Insalata, M.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G.
Lamivudine/Interferon combination therapy in anti-HBe positive chronic hepatitis B patients; a controlled pilot study. 1-gen-2002 Santantonio, TERESA ANTONIA; Niro, Ga; Sinisi, E; Leandro, G; Insalata, M; Guastadisegni, A; Facciorusso, D; Gravinese, E; Andriulli, A; Pastore, G.
Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides. 1-gen-2002 Isaguliants, Mg; Widell, A; Zhang, Sm; Sidorchuk, A; Levi, M; Smirnov, Vd; Santantonio, TERESA ANTONIA; Diepolder, Hm; Pape, Gr; Nordenfelt, E.
Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients 1-gen-2002 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Roldan, E. q.; Castelli, F.; Suter, F.; Pastore, G.; Carosi, G.
High interferon (IFN) daily doses in combination with ribavirin (RBV) are cost effective in the treatment of hepatitis C in HIV coinfected subjects without sustained response to interferon monotherapy 1-gen-2002 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Scalise, G.; Ghinelli, F.; Chiodo, R.; Pastore, G.; Castelli, F.; Carosi, G.
Mostrati risultati da 161 a 180 di 512
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile